Overview

Dexpramipexole Japanese PK Study

Status:
Completed

Trial end date:
2012-02-01

Target enrollment:

Participant gender:

Summary

This is a single and multiple dose, open-label study to evaluate the pharmacokinetics (PK), safety, and tolerability of dexpramipexole administered orally to adult Japanese and Caucasian healthy subjects.

Phase:

Phase 1

Details

Lead Sponsor:

Knopp Biosciences

Collaborator:

Biogen

Treatments:

Pramipexole